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Abstract
Background: Rural sub-Saharan Africa is at an early stage of economic and health transition. It is
predicted that the 21st century will see a serious added economic burden from non-communicable disease
including vascular disease in low-income countries as they progress through the transition. The stage of
vascular disease in a population is thought to result from the prevalence of vascular risk factors. Already
hypertension and stroke are common in adults in sub-Saharan Africa. Using a multidisciplinary approach
we aimed to assess the prevalence of several vascular risk factors in Agincourt, a rural demographic
surveillance site in South Africa.
Methods: We performed a cross sectional random sample survey of adults aged over 35 in Agincourt
(population ≈ 70 000). Participants were visited at home by a trained nurse who administered a
questionnaire, carried out clinical measurements and took a blood sample. From this we assessed
participants' history of vascular risk, blood pressure using an OMRON 705 CP monitor, waist
circumference, body mass index (BMI), ankle brachial index (ABI), and total and HDL cholesterol.
Results: 402 people (24% men) participated. There was a high prevalence of smoking in men, but the
number of cigarettes smoked was small. There was a striking difference in mean BMI between men and
women (22.8 kg/m2 versus 27.2 kg/m2), but levels of blood pressure were very similar. 43% of participants
had a blood pressure greater than 140/90 or were on anti-hypertensive treatment and 37% of participants
identified with measured high blood pressure were on pharmacological treatment. 12% of participants had
an ABI of < 0.9, sugesting the presence of sub-clinical atheroma. 25.6% of participants had a total
cholesterol level > 5 mmol/l.
Conclusion: We found a high prevalence of hypertension, obesity in women, and a suggestion of
subclinical atheroma despite relatively favourable cholesterol levels in a rural South African population.
South Africa is facing the challenge of an emerging epidemic of vascular disease. Research to establish the
social determinates of these risk factors and interventions to reduce both individual and population risk
are required.
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Vascular disease is a major cause of morbidity and mortal-
ity throughout the world, although its manifestations dif-
fer in countries at different stages of economic
development. This has been encapsulated in the theory of
health transition [1-3] that describes a continuum where
an early stage is characterised by hypertensive heart dis-
ease and a large proportion of haemorrhagic stroke. Later
on, driven by increasing prevalence of vascular risk factors
in the population[3], ischaemic heart disease and ischae-
mic stroke due to atherosclerosis emerge[1,3]. Rural sub-
Saharan Africa is at an early stage of economic and health
transition [4] but there is currently very little published
information on the prevalence of vascular risk factors in
the population, although such data will be essential in
planning future health services. Several recent reports
have predicted that the 21st century will see a serious eco-
nomic burden from non-communicable disease in low
income countries [4,5], and have called for action. Hyper-
tension as a vascular risk factor and stroke as a vascular
outcome are important in adults in sub-Saharan Africa
[1,3,6-13]
The high mortality from stroke in Agincourt sub-district
between 1992 and 1995 [10] led to the Southern Africa
Stroke Prevention Initiative (SASPI) [11,12]. This multi-
disciplinary project aimed to describe and address the
burden of stroke and other vascular disease in rural Sub-
Saharan Africa. Among other projects, it included a cross-
sectional survey of the prevalence of vascular risk factors
in the adult population of Agincourt, which we report
here.
The aim of this paper is to describe the prevalence of risk
factors for vascular disease in a rural sub-Saharan popula-
tion aged over 35 years.
Methods
Setting and Population
The Agincourt sub-district is in South Africa's rural north-
east, adjacent to Mozambique, where the Wits/MRC
(Agincourt) Rural Public Health and Health Transitions
Research Unit has been monitoring causes of death, births
and migration in a population of around 70 000 people
since 1992[14]. Each individual has a unique identity
number, as does each household. Data is updated annu-
ally by census, with trained field workers visiting every
household.. This dataset therefore provides a well catego-
rised sampling frame for studies such as this.
The sub-district has 21 villages of varying sizes and is
heavily populated at about 170 persons per sq km. Elec-
tricity is available in most villages, but not all households.
At the time the study was undertaken, some villages had
no standpipe to provide clean water and supply from
standpipes was limited and sporadic in all other villages.
There is high unemployment and, as is common in rural
sub-Saharan Africa, considerable labour migration, espe-
cially in men. Household plots are too small for subsist-
ence agriculture, although crops supplement the diet [15].
Most people access plural health care from allopathic
health professionals, traditional healers, and prophets
linked to churches that offer faith based healing[16].
There are five publicly funded primary care clinics and a
large health centre staffed by nurses, with occasional visits
from doctors. Treatment and drugs are free at these clinics.
Three district hospitals serve the wider district, and there
are a number of private practitioners.
Sample
We stratified the Agincourt villages by size (less than 500
households, and 500 households or more) and by
whether the village was a formal settlement (officially rec-
ognised) or an informal settlement (settled following an
influx of refugees during the Mozambican civil war). Ten
villages were randomly selected: four small informal vil-
lages, three small formal villages, and three large formal
villages (there were no large informal villages). The total
population of the selected villages was 28,715, represent-
ing 43% of the population of the sub-district. A random
sample of individuals from the resident (i.e. excluding
migrant workers) population in selected villages aged 35
years and older, provided 526 individuals. This was
approximately 10% of the population aged 35 years and
over in the selected villages, or 3% of the 16, 705 sub-dis-
trict population aged 35 years and over). We considered
migrant workers or temporary migrants to be people who
were linked to a household and provided financial sup-
port but lived in the area for less than 6 months of the year
because they were employed elsewhere.
Information on age, gender and the household asset score
was available from the Agincourt database. The house-
hold asset score was based on information collected dur-
ing the 2001 census about the type and size of dwelling;
access to water and electricity; appliances and livestock
owned and transport available. The questionnaire con-
tained 34 variables, which were developed in discussion
with local field staff and community members and the
score was developed using a principal component factor
analysis. The score was divided into quintiles labeled: low,
medium-low, medium, medium-high and high economic
status[17]. A similar household economic status index
was reported to discriminate effectively among levels of
economic status in other rural African settings[18].
Making contact with participants
We made at least three attempts to visit each individual. A
second sample provided substitutes for individuals whoPage 2 of 10
(page number not for citation purposes)
BMC Public Health 2007, 7:326 http://www.biomedcentral.com/1471-2458/7/326were ineligible (for example had died, were migrant work-
ers, were aged < 35 years, or were not living there) or who
were untraceable. Subjects who declined to participate,
were too ill, or did not keep appointments were not
replaced. In three households in a remote village the inter-
view was abandoned for logistic reasons.
Consent and ethics
We obtained informed consent from the village headman
and through village community meetings, before starting
work in each village. In addition, each participant was
asked to consent separately in writing to each component
of the study, (the interview, the anthropometric and
blood pressure measurements, and venesection). Many
participants were illiterate and marked the form with a
thumbprint, but we ensured they understood the content
of the form. Ethics committee approval was granted by
both the London School of Hygiene and Tropical Medi-
cine (755) and the University of the Witwatersrand (M02-
04-63).
Interview and clinical examination
In 12 months from July 2002 two specially trained senior
nurses from the local community carried out interviews
and clinical examinations. The interview covered a past
medical history, including hypertension, and smoking
habit. Participants were asked about any treatment for
high blood pressure in the last week, and asked to show
the medication to confirm the name.
The nurses were trained in anthropometric and blood
pressure measurement by a member of staff from the
Medical Research Council, which carried out the South
African Demographic and Health Survey [19]. They meas-
ured height using a portable, collapsible stadiometer
(Leicester Height Measure – Seca, Ltd, Birmingham, UK),
which was placed on a firm level surface. They then asked
participants to remove any headdress and footwear, to
stand on the stadiometer platform with their heels
together touching the backstop to ensure that their spine
at pelvis and shoulder level, as well as the back of their
head touched the upright rod of the stadiometer. The
nurse then positioned the participant's head so that an
imaginary horizontal line joined the corner of the partici-
pant's eye and the upper attachment of their ear to their
head. They then firmly lowered the measuring arm of the
stadiometer onto the participant's head without forcing
their head down. Participants were then asked to move
away from the stadiometer and the nurse read the meas-
urement to the nearest 0.1 cm.
For waist measurement, the nurse asked the participants
to stand upright in a relaxed manner with their arms
slightly away from their sides and their feet about 15 cm
apart. The nurse then placed the measuring tape around
the narrowest part of the bare waist, 2.5 cm above the
umbilicus. In difficult cases, for instance, obese persons,
the nurse stood behind the participant to find the narrow-
est part of the waist. If this was not the narrowest portion
of the waist, they then measured the smallest circumfer-
ence between the xiphi sternum and umbilicus. They took
the measurement with the measuring tape in a horizontal
position to the nearest 0.1 cm after normal expiration,
taking care not to insert their fingers under the tape and
not to let the tape cut into the participant.
Participants were weighed barefoot and wearing at most
light clothing using a UC-321 Precision Health Scale UC-
321 scales (A&D Medical). The scale was placed on a flat
surface and cleaned with disinfectant. A clean paper towel
was placed on top of the scale prior to each measurement.
The nurse then switched the scale on and ensured that it
read zero. They then asked the participant to step onto the
scale and stand with their feet firmly on the middle of the
scale without moving while the nurse recorded the read-
ing to the nearest 0.1 kg.
Sitting blood pressure was measured in the left arm using
an OMRON 705CP blood pressure monitor and an
appropriately sized cuff after the participant had been sit-
ting for five minutes with their arm supported. Three
measures were taken two to three minutes apart. Supine
arm blood pressure was measured with the same monitor
after the participant had been lying for 2 to 3 minutes.
Ankle systolic pressures were measured in the posterior
tibial artery of both legs using a Doppler ultrasound probe
(Huntleigh Mini-Dopplex) and a Mandaus manual digital
blood pressure monitor (PMS instruments) with the cuff
placed just above the malleoli.
When the nurse identified any problem requiring treat-
ment she gave the participant a letter of referral for the
local clinic.
We assessed the quality of the anthropometric measures
on several occasions. About midway through the study the
MRC nurse trainer visited the site and accompanied the
nurses on their visits, assessing their techniques and re-
training as required. Several of us (MT, ST, GH and MC)
visited the site and accompanied the nurses resulting in
approximately monthly quality assessments, and one of
us (MC) was available at least fortnightly on site to man-
age any queries from the nurses.
Blood Analysis
Blood samples were transported in cold boxes, centri-
fuged locally at the end of each day, and transferred by
courier to the University of the Witwatersrand Contract
Laboratory Services. Analysis was done using the RochePage 3 of 10
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were measured using an enzymatic, colorimetric method,
Clinical Definitions
We used the mean of the second and third blood pressure
measurements and the Joint National Committee defini-
tion of hypertension (JNC7) [20] criteria to define hyper-
tension. A person was considered to have high blood
pressure if the systolic pressure was at or greater than 140
mmHg, or the diastolic at or greater than 90 mmHg, or
they were using anti-hypertensives. As with JNC7, we fur-
ther divided high blood pressure into Stage 1 (systolic
140–159 mmHg, and/or diastolic 90–99 mmHg) and
Stage 2 (systolic 160 mmHg or higher, and/or diastolic
100 mmHg or higher).
In developed populations, the ankle brachial index is a
good marker of subclinical peripheral arterial disease and
an indicator of overall atherosclerosis[21]. A cut-off of the
ankle brachial index of 0.9 is commonly used to distin-
guish individuals at high and low risk of clinical athero-
sclerosis. We used the supine systolic pressure together
with the pressure as measured at the ankle (see above) to
calculate the ankle brachial index in each leg. We have
reported the lowest of the two ankle brachial indices,
together with the proportion of participants with an ankle
brachial index at or less than 0.9.
Physical activity
At the time, we were unable to find a validated physical
activity questionnaire that was suitable for use in this
environment where we found no concept of leisure time
physical activity, and where walking carrying a load
formed a major part of daily activity. We therefore
adapted the validated International Physical Activity
Questionnaire (IPAQ)[22], and categorised respondents
as moderately active, low active or sedentary on the basis
of their responses. Table 1 provides details of how
respondents' physical activity was categorised.
Data analysis
We used STATA version 8 [23]. Categorical data was tabu-
lated and confidence intervals for cell percentages calcu-
lated using the cii function. Differences in frequencies
were examined using chi-squared test of the hypothesis
that rows and columns are independent. Continuous clin-
ical measurements were examined and summarised via
their means and 95% confidence intervals.
Results
Response
Four hundred and two people (24% men) participated; a
response rate of 77% (80% women, 68% men). At the
mid year 2003 census update there were around 12 500
people aged over 34 resident in the field site of whom
32% were men, reflecting the dominance of male labour
migration (Collinson M, personal communication).
There was little difference in demographic variables in the
total sample and in the responders (Table 2). Figure 1
shows the people who were replaced in the sample, and
reasons for non-response in the valid sample. The
response rate to different parts of the interview and exam-
ination varied: the lowest response rate was for venepunc-
ture (51%).
Characteristics of the responder population
Table 3 shows the distribution of some lifestyle factors by
gender. There was a high prevalence of smoking in men
(28.4%), but the amount smoked was low. For many men
smoking was too irregular to estimate a daily amount, and
most of the other men reported 5 or less cigarettes daily.
Money was limited and few people could afford the cost
of regular smoking. There were also differences between
men and women in drinking alcohol (Table 3).
Tables 4 shows the distribution of some clinical measure-
ments associated with vascular risk by gender, and Table 5
shows the proportion of respondents with levels of clini-
cal measurements associated with vascular risk. There was
a striking difference in mean body mass index between
men (22.4 kg/m2 95% CI 21.5, 23.3) and women (27.2
kg/m2, 95% CI 26.1, 27.4), and in abdominal obesity
Table 1: Definitions of physical activity categories
Moderate Activity
Any one of: Has a job which involves at least moderate activity
Walks with heavy loads and/or cycles for at least 2.5 hours a week
Does 1 hour or more of vigorous non-work activity, e.g. football
Has a job that involves standing and walking AND Either walks with loads and/or cycles for at least 1 hour, or walks 
without loads for at least 2.5 hours a week.
Low Activity Not sedentary but not active enough to fit the vigorous or moderate activity categories
Sedentary Had no job, or a job that only involves sitting and does no walking, cycling, or vigorous non-work activity.Page 4 of 10
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way that would be expected in the mean blood pressure,
where the systolic pressure was a little higher in the men
(136 mmHg, 95%CI 131, 142) than in the women (132
mmHg, 95%CI 131, 134) (Table 4). This relationship was
unchanged by adjusting for age. There was no significant
difference between men and women in the proportion
with high blood pressure (data not shown).
The mean levels of ABI were similar in men and women,
as was the proportion with an ABI at or below 0.9 (Table
4). The proportion with an ABI at or below 0.9 increased
sharply with age, reaching 32% in those over 65 years. A
fuller report of the ABI findings is available [24].
For comparison with data from other studies, Additional
Table 1 (Age and clinical variables) shows the clinical risk
factors broken down by 10 year age group.
Treatment of clinical vascular risk factors
Drugs from the South African essential drug list are avail-
able free in local clinics in South Africa, and of the 154
people identified at examination as hypertensive, 37
(24.2%) had used pharmacological treatment for blood
pressure in the last week (Table 5). Sixteen were using diu-
retics, 3 using captopril, reserpine, and atenolol respec-
tively, and 18 using combinations of drugs. Three further
people were taking traditional remedies and two were
using other products. Of those using pharmacological
treatment, 19 (51.4%) had a mean blood pressure reading
below 140/90 mm Hg.
No-one was using drugs for treatment of elevated choles-
terol levels. South African guidelines [25] set a reading of
5 mmol/l as the highest desirable level of total cholesterol,
and just over 25% of participants had levels higher than
that (Table 5). Only one person had a cholesterol level
above 7.5 mmol/l. However, the HDL/total cholesterol
ratio was favourable (> 20%) in over 90% of the popula-
tion (Table 5).
Discussion
We have studied risk factors for vascular disease in an
older (35 plus) population in rural Southern Africa, and
found a pattern that is fairly typical of that hypothesised
for populations early in health transition [1,3,26]. High
blood pressure is an important clinical issue, affecting
42% of the population. Elevated total cholesterol levels
affected about a quarter of the population, but the HDL/
total cholesterol ratio was above 20% for over 90% of par-
ticipants. Our study is the first to report on the distribu-
tion of the ABI in a sub-Saharan African population [24].
We found a distribution of ABI that suggests that there is
already considerable sub-clinical atheroma in this popu-
lation, and therefore that the population should be at
increased risk of vascular events in future. Heavy cigarette
smoking is, as yet, uncommon. We observed an unusual
relationship between blood pressure and body size, in
that men were markedly slimmer than women but had
similar levels of blood pressure.
In South Africa, treatment at community clinics and the
drugs prescribed there are free. Nevertheless, the majority
of people with high blood pressure (75.8 %) were not tak-
ing any treatment. Factors that militate against effective
treatment include difficulties with people getting to clin-
ics, difficulties with drug supplies and problems with
Table 2: Comparison of demographic characteristics of total sample and participant sample.
Variable Total sample (N = 525) Participant sample (N = 402)
Female 73.3 (69.3,77.0) 76.4 (71.9,80.4))
Age category (years)
35–44 29.5 (25.7,33.6) 28.9 (24.5, 33.6)
45–54 26.3 (22.6, 30.3) 27.9 (23.5, 32.5)
55–64 18.1 (14.9, 21.7) 17.9 (14.3, 22.0)
65–74 15.1 (12.1, 18.4) 13.4 (10.3, 17.2)
75 plus 11.0 (8.5, 14.0) 11.7 (8.7, 15.2)
Household asset score*
1 (low) 12.5 (9.80, 15.7) 13.3 (10.2, 17.1)
2 177 (14.5, 21.3) 15.4 (12.0, 19.3)
3 29.9 (26.0, 34.0) 30.5 (26.0, 35.3)
4 20.4 (17.0, 24.2) 22.9 (18.9, 27.4)
5 (high) 19.5 (16.1, 23.1) 17.9 (14.2, 22.0)
Numbers shown are percentages and 95% confidence intervals.
* A score based on type and size of dwelling; access to water and electricity; appliances and livestock owned and transport available.Page 5 of 10
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interrelated factors.
Limitations of this research
The study area was widely dispersed with no tarmac roads.
There were long travelling times, delays in repairing
equipment and replenishing supplies, and hesitancy from
a population with little experience of clinical procedures.
The response rate for venepuncture was limited (51%).
This was partly due to the hesitancy mentioned above,
(which in turn may possibly have been related to a general
attitude to allopathic medicine, and therefore a source of
bias), but it was also due in large part to the problems we
encountered in replenishing supplies in time (and there-
fore unlikely to be a source of response bias). Neverthe-
less, our overall response rate was good and the
demographic profile of respondents reflected the popula-
tion reasonably well. The sample size was small, limiting
the power of the study.
The study site was in one of the poorer areas of South
Africa, but there were more facilities and more state sup-
port (disability benefits, pensions) than in most other
parts of sub-Saharan Africa. It is likely, therefore, that the
levels of risk factors are higher than in the rural parts of
other countries in sub-Saharan Africa, but they probably
indicate a trend that can be predicted as the economies of
other countries develop.
How do these data compare with other African data?
We found higher rates of hypertension (44% men, 42%
women) than those reported in the South African Demo-
graphic and Health Survey for (19% men, 21% women)
[19]. Our data are comparable in that our nurses were
trained by a member of staff from that survey, but the age
range of our survey was older (35 years and older com-
pared with 15 years and older in the Demographic and
Health Survey) and this would have the effect of increas-
ing the prevalence of hypertension since blood pressure
increases with age.
There are few studies available before the 1990's reporting
the prevalence of hypertension in non urban black Afri-
cans. One study published in 1972 of "South African
Rural Bantu" women admitted to one hospital reported
that just five of the 485 women studied were hypertensive
[28]. However, the authors did not provide any definition
of hypertension. Two studies in rural Cameroon and one
in a mixed rural and urban population in Nigeria, all pub-
lished in the late 1990s, reported a prevalence of hyper-
tension (using the same definition of hypertension that
we have used) of 15% or less. [29,30] A more recent study
(data collected in 2001) in a group of rural and semi-
urban villages in Ghana found an overall prevalence of
hypertension of 29% in men and women with a mean age
of 55 years[6]. However, a study of socially advantaged
rural area of Tanzania published in 2000, with data col-
lected in 1997, reported a prevalence of hypertension sim-
ilar to the current study (41% and 39% in males and
females respectively aged 35 to 54 years, and 54% and
61% in those aged 55 years or more[31].
Mean total cholesterol levels in our population were
higher than those found from rural areas of North West
South Africa, although that population was much younger
(15 -65 years, mean 37 years) [32]. Our levels were very
similar to those found in the same age range in a socially
advantaged part of rural Tanzania [33].
A ratio of HDL cholesterol to total cholesterol of ≥ 20% is
protective against heart disease[34], and it has been sug-
gested that the high proportion of black Africans with
ratios above this level partly explains the low prevalence
of coronary heart disease in South Africa [35]. We found a
very high proportion of people with this protective ratio
Replacements and final response rateFigure 1
Replacements and final response rate.
Sample of  526
125 replaced 
19 dead 
7 under 35 years 
76 migrant workers 
17 moved away 
6 no contact 
Sample of  526 
124 (24%) Non-response  
• 6 unfit for interview 
• 87 refused 
• 25 missed appointments 
• 3 houses not accessible by 
car 
402 (76%) participantsPage 6 of 10
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Table 4: Mean (95% confidence interval) of clinical measurements by gender.
Clinical measurement Male Female
Height (cms)
N* = 81 M 277 F
171 (170, 173) 159 (158, 160)
Weight (kgs)
N = 83 M 280 F
66.2 (63.5, 68.8) 67.8 (66.0, 69.6)
Body mass index (kg/m2)
N = 80 M 275 F
22.4 (21.5, 23.3) 26.8 (26.1, 27.4)
Waist circumference
N = 79 (M) 278 (F)
82.5 (80.3, 84.8) 83.6 (82.2, 85.0)
Systolic blood pressure (mmHg) N = 86 M 273 F 136 (131, 142) 132 (129, 136)
Diastolic blood pressure (mmHg) N = 86 M 273 F 81 (78, 84) 80 (78, 82)
Ankle Brachial Index (ABI)
N = 252 F, 70 M
1.05 (1.01, 1.08) 1.04 (1.03, 1.06),
Total cholesterol (mmol/l) N = 63 M, 203 F 4.28 (4.04, 4.53) 4.53 (4.39, 4.67)
HDL cholesterol (mmol/l) N = 60 M** 203 F 1.47 (1.34, 1.59) 1.44 (1.39, 1.49)
Percentage (CI) Percentage (CI)
Proportion with abdominal obesity*** 3.80 (0.79, 10.7) 32.7 (27.2, 38.6)
Proportion with ABI <0.9 11.4 (5.07, 21.2) 13.1 (9.19,17.9)
*number of available observations.
** excluding three men with a HDL level at or above 3 mmol/l.
*** Circumference > 102 cms (M), > 88 cms (F) as defined by the National Institute of Health (Obesity research 1998 6(suppl 2) 51S – 209S)
Table 3: Distribution of demographic and lifestyle factors by gender
Variables Male N = 95 Female N = 307 Total N = 402 Significance of difference 
(male v female)
23.6 (19.6, 28.1) 76.4 (71.9,80.4) 100
Age group
35–44 years 16.8 (9.94, 25.9) 32.6 (27.4, 38.1) 28.9 (24.5, 33.6)
45–54 years 29.5 (20.6, 39.7) 27.4 (22.5, 32.7) 27.9 (23.5, 32.5)
55 -64 years 23.2 (15.1, 32.9) 16.3 (12.3, 20.9) 17.9 (14.3, 22.0) d.f.= 4
65–74 years 11.6 (5.92, 19.8) 14.0 (10.3, 18.4) 13.4 (10.3, 17.2) p = 0.007
75 plus years 18.9 (11.6, 28.3) 9.45 (6.42, 13.3) 11.7 (8.72, 15.2)
Household asset score
Low 14.7 (8.29, 23.5) 12.9 (9.34, 17.2) 13.4 (10.2, 17.1)
Medium -low 21.1 (13.6, 30.6) 13.6 (9.92, 18.0) 15.4 (12.0, 19.3)
Medium 25.3 (16.9, 35.2) 32.1 (26.9, 37.7) 30.5 (26.0, 35.3) d.f. = 4
Medium-high 22.1 (14.2, 31.7) 23.2 (18.5, 28.4) 22.9 (18.9, 27.4) p = 0.401
High 16.8 (9.94, 25.9) 18.2 (14.0, 23.0) 17.9 (14.2, 22.0)
Currently smoking at least daily 28.4 (19.6, 38.6) 10.7 (7.50, 14.8) 14.9 (11.6, 18.8) d.f. = 1 p < 0.001
Has never drunk alcohol 28.3 (19.4, 38.6) 74.9 (69.6, 79.7) 63.9 (59.0, 68.7)
Has drunk alcohol but not as much as once a week in the 
last 12 months
14.1 (7.74, 23.0) 11.7 (8.29, 15.9) 12.3 (9.19, 15.9) d.f. = 2
Drinks alcohol at least once a week in the last 12 months 57.6 (46.9, 67.9) 13.4 (9.73, 17.8) 23.8 (19.6, 28.3) p < 0.001
Physical activity
Moderately active 68.4 (58.1, 77.6) 74.9 (69.7, 79.7) 73.4 (68.8, 77.6)
Low active 20.0 (12.5, 29.5) 18.2 (14.1, 23.0) 18.7 (15.0, 22.8) d.f. = 2
Sedentary 11.6 (5.92, 19.8) 6.84 (4.28, 10.3) 8.0 (5.5, 11.1) p = 0.275
Numbers shown are percentages and 95% confidence intervals.
*Only a small minority of smokers were able to estimate a daily number smoked
BMC Public Health 2007, 7:326 http://www.biomedcentral.com/1471-2458/7/326(95%), similar to that found in the Western Cape [36]. We
have previously reported little extracranial atherosclerotic
disease in stroke survivors in our population[11], and a
favourable HDL:TC ratio may be part of the explanation
for this.
The levels of obesity were lower than levels reported in
urban black people in South Africa [37]. The large differ-
ence in obesity between men and women that we
observed has been reported, although not explained,
throughout South Africa [34,37] but not outside sub-
Saharan Africa [38].
Blood pressure and body size in Africa and the African 
diaspora
Several studies from sub-Saharan Africa have considered
the relationship between body mass index and/or waist
circumference and blood pressure. Three studies have
explored the slope of the relationship between body mass
index and blood pressure in African women [39-41]. All
three found non-linear associations, and two of them
found that the slope of the relationship between systolic
blood pressure and body mass index flattened out in
larger women[40,41]. A similar relationship may explain
the puzzling differences in body mass index, but not in
blood pressure, between men and women in this study.
Conclusion
Work carried out in the same research site has recently
shown that deaths from non-communicable disease have
increased by 20% between 1992 and 2003 [42](p44). We
have also previously reported a high rate of death from
stroke [43]and a high prevalence of survivors of stroke in
the research site[11]. These findings, taken together with
the findings reported here of a high prevalence of hyper-
tension and of probable sub-clinical atheroma indicate
that South Africa is facing the challenge of an emerging
epidemic of vascular disease.
This view is supported by other researchers. Murray and
colleagues[44] have argued for a 'frameshift in thinking
about priorities and public health strategies for less devel-
oped regions' (p722), calling for a new emphasis on
addressing the burden of vascular disease in low-income
as well as high-income countries. They have estimated
that, in countries such as South Africa, interventions to
address vascular risk will be cost-effective both at the per-
sonal level of using drugs to reduce risk, and at the social
level of addressing the salt content of food, and providing
health education.
Sub-Saharan Africa is already challenged by HIV/AIDS
and by the other diseases of poverty. Nevertheless, as the
World Health Organisation has argued [45], action to
address the emerging threat of non-communicable dis-
ease in low and middle income countries is urgently
needed. Social level interventions such as salt reduction in
food (as a means to reduce population levels of blood
pressure) need commitment at national level. Providing
individual interventions targeted at vascular disease will
require a shift in the paradigm of medical care. Limited
resources and skills are a reality, but Sub-Saharan Africa is
following the predicted path towards an epidemic of vas-
cular disease, and innovative interventions are needed to
avert this outcome.
Abbreviations
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HDL: high density lipoprotein
IPAQ: International Physical Activity Questionnaire
Table 5: Respondents with clinical measurements associated with vascular risk
Blood pressure levels and anti-hypertensive treatment Percentage (95% CI)
Normal blood pressure, no treatment 57.1% (51.8, 62.3)
High blood pressure, no pharmacological treatment 32.6% (27.8, 37.7)
JNC7 Stage 1 high blood pressure, no pharmacological treatment 17.6% (13.8, 21.9)
JNC7 Stage 2 high blood pressure, no pharmacological treatment 15.0% (11.5, 19.2)
On pharmacological treatment for high blood pressure 10.3% (7.3, 13.9)
Normal blood pressure on pharmacological treatment 5.29% (3.21, 8.14)
JNC7 Stage 1 high blood pressure, on pharmacological treatment 2.79% (1.34, 5.06)
JNC7 Stage 2 high blood pressure, on pharmacological treatment 2.23% (0.967, 4.34)
Lipid profilei
Total cholesterol > 5.0 mmol/l 25.6 (20.4, 31.2)
HDL cholesterol < 1.2 mmol/l 22.2 (17.3, 27.7)
HDL:total cholesterol ≥ 20%ii 93.5 (89.9, 96.2)
i no-one was using treatment to lower cholesterol levels.
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